Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1616-1624

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suarna, C.
Right arrow Articles by Stocker, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suarna, C.
Right arrow Articles by Stocker, R.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1616-1624.)
© 1995 American Heart Association, Inc.


Articles

Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of {alpha}-Tocopherol and Ascorbate

Cacang Suarna; Roger T. Dean; James May; Roland Stocker

From the Biochemistry (C.S., R.S.) and Cell Biology (R.T.D.) Groups, The Heart Research Institute, and the Department of Vascular Surgery (J.M.), Royal Prince Alfred Hospital, Camperdown, Australia.

Correspondence to Dr Roland Stocker, The Heart Research Institute, 145 Missenden Rd, Camperdown, NSW 2050, Australia.

Abstract We assessed the antioxidant status and contents of unoxidized and oxidized lipids in freshly obtained, homogenized samples of both normal human iliac arteries and carotid and femoral atherosclerotic plaque. Optimal sample preparation involved homogenization of human atherosclerotic plaque for 5 minutes, which resulted in recovery of most of the unoxidized and oxidized lipids without substantial destruction of endogenous vitamins C and E and 87% and 43% recoveries of added standards of {alpha}-tocotrienol and isoascorbate, respectively. The total protein, lipid, and antioxidant levels obtained from human plaque varied among donors, although the reproducibility of replicates from a single sample was within 3%, except for ubiquinone-10 and ascorbate, which varied by 20% and 25%, respectively. Plaque samples contained significantly more ascorbate and urate than control arteries, with no discernible difference in the vitamin C redox status between plaque and control materials. The concentrations of {alpha}-tocopherol and ubiquinone-10 were comparable in plaque samples and control arteries. However, approximately 9 mol percent of plaque {alpha}-tocopherol was present as {alpha}-tocopherylquinone, whereas this oxidation product of vitamin E was not detectable in control arteries. Coenzyme Q10 in plaque and control arteries was only detected in the oxidized form ubiquinone-10, although coenzyme Q10 oxidation may have occurred during processing. The most abundant of all studied lipids in plaque samples was free cholesterol, followed by cholesteryl oleate and cholesteryl linoleate (Ch18:2). Approximately 30% of plaque Ch18:2 was oxidized, with 17%, 12%, and 1% present as fatty acyl hydroxides, ketones, and hydroperoxides, respectively. In comparison, 7-ketocholesterol was detected at an {approx}75-fold lower concentration. Normal arteries contained similar levels of protein as atherosclerotic arteries, much less free cholesterol, and no detectable amounts of unoxidized or oxidized cholesteryl esters. Together, these results demonstrate the coexistence in human plaque of large amounts of oxidized cholesteryl esters with significant concentrations of ascorbate and vitamin E in their reduced, antioxidant-active form. We conclude that compared with healthy human arteries, advanced atherosclerotic plaques are not deficient in the antioxidant vitamins C and E, despite the occurrence of massive lipid oxidation.


Key Words: antioxidants • atherosclerosis • oxidative stress • 7-ketocholesterol • vitamin E




This article has been cited by other articles:


Home page
BloodHome page
M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio, and E. A. Podrez
Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI
Blood, February 15, 2008; 111(4): 1962 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Strasak, E. Ruttmann, L. Brant, C. Kelleher, J. Klenk, H. Concin, G. Diem, K. Pfeiffer, H. Ulmer, and and the VHM&PP Study Group
Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men
Clin. Chem., February 1, 2008; 54(2): 273 - 284.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Alderman
Podagra, Uric Acid, and Cardiovascular Disease
Circulation, August 21, 2007; 116(8): 880 - 883.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Choy, K. Beck, F. Y. Png, B. J. Wu, S. B. Leichtweis, S. R. Thomas, J. Y. Hou, K. D. Croft, T. A. Mori, and R. Stocker
Processes Involved in the Site-Specific Effect of Probucol on Atherosclerosis in Apolipoprotein E Gene Knockout Mice
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1684 - 1690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. K. Witting, B. J. Wu, M. Raftery, P. Southwell-Keely, and R. Stocker
Probucol Protects against Hypochlorite-induced Endothelial Dysfunction: IDENTIFICATION OF A NOVEL PATHWAY OF PROBUCOL OXIDATION TO A BIOLOGICALLY ACTIVE INTERMEDIATE
J. Biol. Chem., April 22, 2005; 280(16): 15612 - 15618.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. S. Rayner, B.-J. Wu, M. Raftery, R. Stocker, and P. K. Witting
Human S-Nitroso Oxymyoglobin Is a Store of Vasoactive Nitric Oxide
J. Biol. Chem., March 18, 2005; 280(11): 9985 - 9993.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kontush, M. J. Chapman, and R. Stocker
Vitamin E Is Not Deficient in Human Atherosclerotic Plaques
Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): e139 - e140.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Micheletta, S. Natoli, M. Misuraca, E. Sbarigia, U. Diczfalusy, and L. Iuliano
Vitamin E Supplementation in Patients With Carotid Atherosclerosis: Reversal of Altered Oxidative Stress Status in Plasma but not in Plaque
Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 136 - 140.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Scholz, A. Yndestad, J. K. Damas, T. Waehre, S. Tonstad, P. Aukrust, and B. Halvorsen
8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
Cardiovasc Res, October 1, 2003; 59(4): 945 - 954.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. J. Weir, S. W. Muir, M. R. Walters, and K. R. Lees
Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute Stroke
Stroke, August 1, 2003; 34(8): 1951 - 1956.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. A. Patterson, E. T. M. Horsley, and D. S. Leake
Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid
J. Lipid Res., March 1, 2003; 44(3): 512 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Pankhurst, X. L. Wang, D. E. Wilcken, G. Baernthaler, U. Panzenbock, M. Raftery, and R. Stocker
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein
J. Lipid Res., February 1, 2003; 44(2): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
S.E. GARIBALLA, T.P. HUTCHIN, and A.J. SINCLAIR
Antioxidant capacity after acute ischaemic stroke
QJM, October 1, 2002; 95(10): 685 - 690.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Huber, H. Boechzelt, B. Karten, M. Surboeck, V. N. Bochkov, B. R. Binder, W. Sattler, and N. Leitinger
Oxidized Cholesteryl Linoleates Stimulate Endothelial Cells to Bind Monocytes via the Extracellular Signal-Regulated Kinase 1/2 Pathway
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Chancharme, P. Therond, F. Nigon, S. Zarev, A. Mallet, E. Bruckert, and M. J. Chapman
LDL particle subclasses in hypercholesterolemia: molecular determinants of reduced lipid hydroperoxide stability
J. Lipid Res., March 1, 2002; 43(3): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Shihabi, W.-G. Li, F. J. Miller Jr., and N. L. Weintraub
Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H797 - H802.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. C. Terentis, S. R. Thomas, J. A. Burr, D. C. Liebler, and R. Stocker
Vitamin E Oxidation in Human Atherosclerotic Lesions
Circ. Res., February 22, 2002; 90(3): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Upston, X. Niu, A. J. Brown, R. Mashima, H. Wang, R. Senthilmohan, A. J. Kettle, R. T. Dean, and R. Stocker
Disease Stage-Dependent Accumulation of Lipid and Protein Oxidation Products in Human Atherosclerosis
Am. J. Pathol., February 1, 2002; 160(2): 701 - 710.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Thomas, S. B. Leichtweis, K. Pettersson, K. D. Croft, T. A. Mori, A. J. Brown, and R. Stocker
Dietary Cosupplementation With Vitamin E and Coenzyme Q10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 585 - 593.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. B. O'Donnell and B. A. Freeman
Interactions Between Nitric Oxide and Lipid Oxidation Pathways : Implications for Vascular Disease
Circ. Res., January 19, 2001; 88(1): 12 - 21.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, W. Palinski, and J. L. Witztum
Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C.-C. Hsieh, M.-H. Yen, C.-H. Yen, and Y.-T. Lau
Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells
Cardiovasc Res, January 1, 2001; 49(1): 135 - 145.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. de Nigris, T. Youssef, S. Ciafre, F. Franconi, V. Anania, G. Condorelli, W. Palinski, and C. Napoli
Evidence for Oxidative Activation of c-Myc-Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits : Protective Effects of Vitamin E
Circulation, October 24, 2000; 102(17): 2111 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. C. Carr, B.-Z. Zhu, and B. Frei
Potential Antiatherogenic Mechanisms of Ascorbate (Vitamin C) and {alpha}-Tocopherol (Vitamin E)
Circ. Res., September 1, 2000; 87(5): 349 - 354.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Patel, A.-L. Levonen, J. H. Crawford, and V. M. Darley-Usmar
Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis
Cardiovasc Res, August 18, 2000; 47(3): 465 - 474.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. K. Witting, K. Pettersson, J. Letters, and R. Stocker
Site-Specific Antiatherogenic Effect of Probucol in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20 (8): e26 - e33.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Carr, M. R. McCall, and B. Frei
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species : Reaction Pathways and Antioxidant Protection
Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1716 - 1723.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Memon, I. Staprans, M. Noor, W. M. Holleran, Y. Uchida, A. H. Moser, K. R. Feingold, and C. Grunfeld
Infection and Inflammation Induce LDL Oxidation In Vivo
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1536 - 1542.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski
In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression
Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 689 - 697.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. J. Brown, E. L. Mander, I. C. Gelissen, L. Kritharides, R. T. Dean, and W. Jessup
Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells: accumulation of oxidized esters in lysosomes
J. Lipid Res., February 1, 2000; 41(2): 226 - 237.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Baoutina, R. T. Dean, and W. Jessup
Macrophages Can Decrease the Level of Cholesteryl Ester Hydroperoxides in Low Density Lipoprotein
J. Biol. Chem., January 21, 2000; 275(3): 1635 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. J. Schroepfer Jr.
Oxysterols: Modulators of Cholesterol Metabolism and Other Processes
Physiol Rev, January 1, 2000; 80(1): 361 - 554.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Massaeli, J. A. Austria, and G. N. Pierce
Chronic Exposure of Smooth Muscle Cells to Minimally Oxidized LDL Results in Depressed Inositol 1,4,5-Trisphosphate Receptor Density and Ca2+ Transients
Circ. Res., September 17, 1999; 85(6): 515 - 523.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. C. Gelissen, K.-A. Rye, A. J. Brown, R. T. Dean, and W. Jessup
Oxysterol efflux from macrophage foam cells: the essential role of acceptor phospholipid
J. Lipid Res., September 1, 1999; 40(9): 1636 - 1646.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Niu, V. Zammit, J. M. Upston, R. T. Dean, and R. Stocker
Coexistence of Oxidized Lipids and {alpha}-Tocopherol in All Lipoprotein Density Fractions Isolated From Advanced Human Atherosclerotic Plaques
Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1708 - 1718.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. H. Alderman, H. Cohen, S. Madhavan, and S. Kivlighn
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Hypertension, July 1, 1999; 34(1): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. M. Letters, P. K. Witting, J. K. Christison, A. W. Eriksson, K. Pettersson, and R. Stocker
Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice
J. Lipid Res., June 1, 1999; 40(6): 1104 - 1112.
[Abstract] [Full Text]


Home page
FASEB J.Home page
J. F. KEANEY JR., D. I. SIMON, and J. E. FREEDMAN
Vitamin E and vascular homeostasis: implications for atherosclerosis
FASEB J, June 1, 1999; 13(9): 965 - 975.
[Abstract] [Full Text]


Home page
FASEB J.Home page
J. M. UPSTON, A. C. TERENTIS, and R. STOCKER
Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement
FASEB J, June 1, 1999; 13(9): 977 - 994.
[Abstract] [Full Text]


Home page
FASEB J.Home page
P. K. WITTING, K. PETTERSSON, A.-M. ÖSTLUND-LINDQVIST, C. WESTERLUND, A. W. ERIKSSON, and R. STOCKER
Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
FASEB J, April 1, 1999; 13(6): 667 - 675.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Chancharme, P. Therond, F. Nigon, S. Lepage, M. Couturier, and M. J. Chapman
Cholesteryl Ester Hydroperoxide Lability Is a Key Feature of the Oxidative Susceptibility of Small, Dense LDL
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 810 - 820.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Kritharides, J. Upston, W. Jessup, and R. T. Dean
Accumulation and metabolism of low density lipoprotein-derived cholesteryl linoleate hydroperoxide and hydroxide by macrophages
J. Lipid Res., December 1, 1998; 39(12): 2394 - 2405.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
B. Karten, H. Boechzelt, P. M. Abuja, M. Mittelbach, K. Oettl, and W. Sattler
Femtomole analysis of 9-oxononanoyl cholesterol by high performance liquid chromatography
J. Lipid Res., July 1, 1998; 39(7): 1508 - 1519.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Lapenna, S. de Gioia, G. Ciofani, A. Mezzetti, S. Ucchino, A. M. Calafiore, A. M. Napolitano, C. Di Ilio, and F. Cuccurullo
Glutathione-Related Antioxidant Defenses in Human Atherosclerotic Plaques
Circulation, May 19, 1998; 97(19): 1930 - 1934.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Garner, A. R. Waldeck, P. K. Witting, K.-A. Rye, and R. Stocker
Oxidation of High Density Lipoproteins. II. EVIDENCE FOR DIRECT REDUCTION OF LIPID HYDROPEROXIDES BY METHIONINE RESIDUES OF APOLIPOPROTEINS AI AND AII
J. Biol. Chem., March 13, 1998; 273(11): 6088 - 6095.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Lehto, L. Niskanen, T. Ronnemaa, and M. Laakso
Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus
Stroke, March 1, 1998; 29(3): 635 - 639.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Neuzil, J. K. Christison, E. Iheanacho, J.-C. Fragonas, V. Zammit, N. H. Hunt, and R. Stocker
Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis
J. Lipid Res., February 1, 1998; 39(2): 354 - 368.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Martin and B. Frei
Both Intracellular and Extracellular Vitamin C Inhibit Atherogenic Modification of LDL by Human Vascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1583 - 1590.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Neuzil, P. K. Witting, and R. Stocker
alpha -Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids
PNAS, July 22, 1997; 94(15): 7885 - 7890.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Fielding, A. Bist, and P. E. Fielding
Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers
PNAS, April 15, 1997; 94(8): 3753 - 3758.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Goulinet and M. J. Chapman
Plasma LDL and HDL Subspecies Are Heterogenous in Particle Content of Tocopherols and Oxygenated and Hydrocarbon Carotenoids: Relevance to Oxidative Resistance and Atherogenesis
Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 786 - 796.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. Garner, D. van Reyk, R. T. Dean, and W. Jessup
Direct Copper Reduction by Macrophages. ITS ROLE IN LOW DENSITY LIPOPROTEIN OXIDATION
J. Biol. Chem., March 14, 1997; 272(11): 6927 - 6935.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Thomas, J. Neuzil, and R. Stocker
Cosupplementation With Coenzyme Q Prevents the Prooxidant Effect of {alpha}-Tocopherol and Increases the Resistance of LDL to Transition Metal–Dependent Oxidation Initiation
Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 687 - 696.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. M. Abu-Soud and S. L. Hazen
Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases
J. Biol. Chem., November 22, 2000; 275(48): 37524 - 37532.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. C. Terentis, S. R. Thomas, J. A. Burr, D. C. Liebler, and R. Stocker
Vitamin E Oxidation in Human Atherosclerotic Lesions
Circ. Res., February 22, 2002; 90(3): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Huber, H. Boechzelt, B. Karten, M. Surboeck, V. N. Bochkov, B. R. Binder, W. Sattler, and N. Leitinger
Oxidized Cholesteryl Linoleates Stimulate Endothelial Cells to Bind Monocytes via the Extracellular Signal-Regulated Kinase 1/2 Pathway
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 581 - 586.
[Abstract] [Full Text] [PDF]